fda glp-1 warning november 2025 Societies take stand against off-brand GLP-1s over safety concerns fda glp-1 warning 2025 november

If you are experiencing significant gastrointestinal distress on semaglutide, contact your healthcare provider

Our goal is to offer you not just a treatment, but a partnership in health

Some patients have reported symptoms such as brain fog, dizziness, fatigue, headaches, or changes in mood, but determining the cause can be challenging

Similar findings were reported in a prospective perioperative gastric ultrasonography study, in which semaglutide use within 10 days of elective procedures was associated with a markedly higher prevalence of increased residual gastric content compared with controls (40% vs

Constipation : Conversely, others may face constipation due to slowed gut movement

Clinical trials show that nausea and altered appetite sensations affect 2550% of users in the first month, but these reactions typically diminish within 48 weeks as your body adapts